Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -119,721 | -92,295 | -64,403 | -31,021 | -65,002 |
| Depreciation Amortization | 1,087 | 568 | 290 | 16 | -3,238 |
| Accounts receivable | 268 | -1,857 | -345 | 70 | 81,311 |
| Accounts payable and accrued liabilities | 1,017 | -1,880 | -2,192 | -1,362 | 2,392 |
| Other Working Capital | -33,632 | -21,822 | -17,304 | -11,814 | 30,262 |
| Other Operating Activity | 18,514 | 15,082 | 12,798 | 6,216 | -61,035 |
| Operating Cash Flow | $-132,467 | $-102,204 | $-71,156 | $-37,895 | $-15,310 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,596 | -1,970 | -1,763 | -658 | -3,521 |
| Purchase Of Investment | -133,929 | -121,426 | -114,790 | -76,924 | -465,685 |
| Sale Of Investment | 261,971 | 201,418 | 159,687 | 118,783 | 374,347 |
| Investing Cash Flow | $125,446 | $78,022 | $43,134 | $41,201 | $-94,859 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 816 | 680 | 595 | 82 | 114,015 |
| Financing Cash Flow | $816 | $680 | $595 | $82 | $114,015 |
| Beginning Cash Position | 74,241 | 74,241 | 74,241 | 74,241 | 70,395 |
| End Cash Position | 68,036 | 50,739 | 46,814 | 77,629 | 74,241 |
| Net Cash Flow | $-6,205 | $-23,502 | $-27,427 | $3,388 | $3,846 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,467 | -102,204 | -71,156 | -37,895 | -15,310 |
| Capital Expenditure | -2,596 | -1,970 | -1,763 | -658 | -3,521 |
| Free Cash Flow | -135,063 | -104,174 | -72,919 | -38,553 | -18,831 |